(Q34341847)

1 August 2017

1 reference

title

Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? (English)

1 reference

attention deficit hyperactivity disorder

1 August 2017

main subject

0 references

1 reference

Todd RD

1

1 reference

1 August 2017

Botteron KN

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

published in

Biological Psychiatry

1 reference

1 August 2017

volume

50

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

151-158

1 reference

Catecholamine modulation of prefrontal cortical cognitive function

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Genetics of childhood disorders: XVIII. ADHD, Part. 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Reduced brain metabolism in hyperactive girls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Intravenous dextroamphetamine and brain glucose metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Neurobiology of attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD genetically heterogeneous?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Is there a ?dopaminergic glial cell??

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Binding sites for [3H]dopamine and dopamine-antagonists on cultured astrocytes of rat striatum and spinal cord: an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Physiological and drug-induced changes in the glycogen content of mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Focal Cerebral Hypoperfusion in Children With Dysphasia and/or Attention Deficit Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Focal cerebral dysfunction in developmental learning disabilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Striatal dysfunction in attention deficit and hyperkinetic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Neurotransmitters regulate energy metabolism in astrocytes: implications for the metabolic trafficking between neural cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Studies on the relation of chemical structure to glycogenolytic activity in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Genetics of attention deficit/hyperactivity disorder: are we ready for molecular genetic studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Genetics of childhood disorders: XXI. ADHD, part 5: a behavioral genetic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

The dopamine receptor DRD4 gene: are duplications distracting?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Brain metabolism in teenagers with attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Cerebral glucose metabolism in adults with hyperactivity of childhood onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

Pharmacological and molecular evidence for dopamine D1 receptor expression by striatal astrocytes in culture

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901173-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(01)01173-8

1 reference

1 August 2017

1 reference